Alternatively, the induction of C/EBP targets and features of ATII differentiation could be an adaptive response independent of the LKB1-SIK axis of tumor suppression that facilitates the persistence of neoplastic cells when challenged by the reactivation of LKB1 signaling. This evidence concerns the gene CEBPA and neoplasm.